JUNE SPECIAL OFFER - Deep Sea Secret Promotion at Quan Spa, JW Marriott Khao Lak Resort

Food and Healthcare Press Releases Thursday June 7, 2012 12:54
Bangkok--7 Jun--JW Marriott Khao Lak Resort & Spa

After a day of exposure to sun, sea and sand, energize yourself with a combination of body treatments to revive yourself with marine and mineral salts with uplifting essential oils to render your skin smooth, stimulate circulation, bring back radiance and a healthy glow following by our signature body massage for a rejuvenating experience at Quan Spa, JW Marriott Khao Lak Resort & Spa.

The 2-hour treatment Includes;
  • Sea Salt Scrub (30 minutes)
  • Andaman Rejuvenation Massage 90 Minutes
Priced at 3,900 Baht
This Promotion is valid from 1st -30th June 2012
For more information and reservations please contact Tel: +66 76 584 888 ext. 8122. Visit us at jwmarriottkhaolak.com

Latest Press Release

Medical Device Manufacturer Advant Medical Celebrates Its 25th Anniversary

Advant is a successful medical device manufacturer with corporate offices located in Galway, Ireland. For a quarter of a century, Advant has seen significant growth and development expanding into two locations in Ireland, Mexico and Costa Rica. With over...

Michel Orsinger Assumes Role as Chairman of Limacorporate#s Advisory Board

LimaCorporate is pleased to announce that Michel Orsinger, Board Member of LimaCorporate's Advisory Board, will assume the role of Chairman of the Board. Michel joined the Advisory Board mid-2017 following a long and successful global career in...

Merck and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer

Merck and Pfizer Inc. (NYSE: PFE) today announced that the Phase III JAVELIN Ovarian 200 trial evaluating avelumab* alone or in combination with pegylated liposomal doxorubicin (PLD), a type of chemotherapy, compared with PLD did not meet the...

APEC#s Rare Disease Action Plan Sets Precedent to Integrate Rare Disease Care by 2025

- Asia-Pacific Economic Cooperation (APEC) Life Sciences Innovation Forum (LSIF) Rare Disease Network comprises Rare Disease International, Queensland University of Technology and Shire (representing as industry co-chair). - Aims to define, diagnose and...

Grunenthal Acquires Averitas Pharma and Establishes Commercial Footprint in the US

Grunenthal announced today that it has acquired the US-based pharmaceutical company Averitas Pharma, thereby extending its commercial footprint to the United States. Averitas Pharma will be commercialising the pain patch Qutenza(R) (8 % capsaicin) for...

Related Topics